tryptophan has been researched along with lenalidomide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, A; Hagiwara, S; Hirade, K; Iida, S; Inagaki, H; Kinoshita, S; Komatsu, H; Kusumoto, S; Maeda, Y; Marumo, Y; Masaki, A; Nakashima, T; Narita, T; Ri, M; Suzuki, T; Tachita, T | 1 |
1 other study(ies) available for tryptophan and lenalidomide
| Article | Year |
|---|---|
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide-treated myeloma patients.
Topics: Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lenalidomide; Multiple Myeloma; Tryptophan | 2023 |